1. Report Overview
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
3.3. PEST-Analysis
3.4. Porter's Diamond Model for the United States Pharmacovigilance Market
3.5. IGR-Growth Matrix Analysis
3.6. Competitive Landscape in the United States Pharmacovigilance Market
4. United States Pharmacovigilance
Market by Product
4.1. Preclinical
4.2. Phase I
4.3. Phase II
4.4. Phase III
4.5. Phase IV
5. United States Pharmacovigilance
Market by Service Provider
5.1. In House
5.2. Contract Outsourcing
6. United States Pharmacovigilance
Market by Type
6.1. Type Dashboard
6.2. Spontaneous Reporting
6.3. Intensified ADR Reporting
6.4. Targeted Spontaneous Reporting
6.5. Other Types
7. United States Pharmacovigilance
Market by End Use
7.1. Hospitals
7.2. Research Organizations
7.3. Industrial
8. Company Profiles
8.1. Company 1
8.2. Company 2
8.3. Company 3
8.4. Company 4
8.5. Company 5
1. Report Overview
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
3.3. PEST-Analysis
3.4. Porter's Diamond Model for the United States Pharmacovigilance Market
3.5. IGR-Growth Matrix Analysis
3.6. Competitive Landscape in the United States Pharmacovigilance Market
4. United States Pharmacovigilance
Market by Product
4.1. Preclinical
4.2. Phase I
4.3. Phase II
4.4. Phase III
4.5. Phase IV
5. United States Pharmacovigilance
Market by Service Provider
5.1. In House
5.2. Contract Outsourcing
6. United States Pharmacovigilance
Market by Type
6.1. Type Dashboard
6.2. Spontaneous Reporting
6.3. Intensified ADR Reporting
6.4. Targeted Spontaneous Reporting
6.5. Other Types
7. United States Pharmacovigilance
Market by End Use
7.1. Hospitals
7.2. Research Organizations
7.3. Industrial
8. Company Profiles
8.1. Company 1
8.2. Company 2
8.3. Company 3
8.4. Company 4
8.5. Company 5